5 unknown. 5 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Unknown 5 |
| Phase 2 | 2 | Unknown 2 |
Follow Hematologic Malignancies: new trials by email Literature Review of Hematologic Malignancies trials Research Report on Hematologic Malignancies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of CN202 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies CN202 - Locally Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 / Phase 2 | Unknown | Curon Biopharmaceutical (Australia) Co Pty Ltd | 164 | 2021-10-22 | 2021-08-31 |
| A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies Venetoclax, ethinyl estradiol/levonorgestrel - Hematologic Malignancies | Phase 1 | Unknown | AbbVie | 12 | 2019-07-30 | 2024-08-29 |
| Study of a Humanized Antibody Initiated 2 Months After an HLA Matched Allogenic Stem Cell Transplantation Monalizumab - Hematologic Malignancies | Phase 1 | Unknown | Institut Paoli-Calmettes | 18 | 2016-11-28 | 2018-09-19 |
| A Study of HMPL-523 in Relapsed or Refractory Hematologic Malignancies HMPL-523 - Hematologic Malignancies | Phase 1 | Unknown | Hutchison Medipharma Limited | 78 | 2015-11-01 | 2020-09-11 |
| Umbilical Cord Derived Mesenchymal Stromal Cells For The Treatment of Severe Steroid-resistant Graft Versus Host Disease UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELLS (UC-MSC) - Hematologic Malignancies | Phase 1 / Phase 2 | Unknown | A.O. Ospedale Papa Giovanni XXIII | 47 | 2013-09-01 | 2019-01-18 |
Hematologic Neoplasms (5) · Lymphoma, Non-Hodgkin (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Recurrence (1)
Hematologic Diseases (5) · Hemic and Lymphatic Diseases (5) · Neoplasms by Site (5) · Neoplasms (4) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Disease Attributes (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoproliferative Disorders (1) · Neoplasms by Histologic Type (1) · Neoplastic Processes (1)
Ethinyl Estradiol-Norgestrel Combination (1) · monalizumab (1) · venetoclax (1)
A.O. Ospedale Papa Giovanni XXIII (1) · AbbVie (1) · Curon Biopharmaceutical (Australia) Co Pty Ltd (1) · Hutchison Medipharma Limited (1) · Institut Paoli-Calmettes (1)
Australia (2) · France (1) · Italy (1) · United States (1)
Alessandro Rambaldi, MD (1) · Chen Yu, MD (1) · Gary Richardson (1) · Morteza Aghmesheh (1)
PMID 16732175, PMID 18468541, PMID 18703664, PMID 18820709, PMID 20350611, PMID 21393326, PMID 21417678